NO2005018I2 - 2-(2-Nitro-4-trifluormetylbenzoyl) 1,3-cykloheksa ndion eller et salt derav (forkortelse:NTBC) - Google Patents

2-(2-Nitro-4-trifluormetylbenzoyl) 1,3-cykloheksa ndion eller et salt derav (forkortelse:NTBC)

Info

Publication number
NO2005018I2
NO2005018I2 NO2005018C NO2005018C NO2005018I2 NO 2005018 I2 NO2005018 I2 NO 2005018I2 NO 2005018 C NO2005018 C NO 2005018C NO 2005018 C NO2005018 C NO 2005018C NO 2005018 I2 NO2005018 I2 NO 2005018I2
Authority
NO
Norway
Prior art keywords
cyclohexanedione
ntbc
trifluoromethylbenzoyl
abbreviation
nitro
Prior art date
Application number
NO2005018C
Other languages
English (en)
Other versions
NO2005018I1 (no
Original Assignee
Syngenta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919113622A external-priority patent/GB9113622D0/en
Priority claimed from GB929206412A external-priority patent/GB9206412D0/en
Application filed by Syngenta Ltd filed Critical Syngenta Ltd
Publication of NO2005018I1 publication Critical patent/NO2005018I1/no
Publication of NO2005018I2 publication Critical patent/NO2005018I2/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Hydrogenated Pyridines (AREA)
NO2005018C 1991-06-24 2005-08-31 2-(2-Nitro-4-trifluormetylbenzoyl) 1,3-cykloheksa ndion eller et salt derav (forkortelse:NTBC) NO2005018I2 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919113622A GB9113622D0 (en) 1991-06-24 1991-06-24 Medicinal agents
GB929206412A GB9206412D0 (en) 1992-03-24 1992-03-24 Pharmaceutical compositions
PCT/GB1992/001094 WO1993000080A1 (en) 1991-06-24 1992-06-18 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO2005018I1 NO2005018I1 (no) 2005-09-26
NO2005018I2 true NO2005018I2 (no) 2008-02-11

Family

ID=26299120

Family Applications (3)

Application Number Title Priority Date Filing Date
NO934798A NO304923B1 (no) 1991-06-24 1993-12-23 Farmas°°ytisk preparat inneholdende 2-(2-nitro-4-trifluormetylbenzoyl)-1,3-cykloheksandion eller et farmas°ytisk godtagbart salt derav
NO2005018C NO2005018I2 (no) 1991-06-24 2005-08-31 2-(2-Nitro-4-trifluormetylbenzoyl) 1,3-cykloheksa ndion eller et salt derav (forkortelse:NTBC)
NO2017045C NO2017045I1 (no) 1991-06-24 2017-08-23 Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO934798A NO304923B1 (no) 1991-06-24 1993-12-23 Farmas°°ytisk preparat inneholdende 2-(2-nitro-4-trifluormetylbenzoyl)-1,3-cykloheksandion eller et farmas°ytisk godtagbart salt derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2017045C NO2017045I1 (no) 1991-06-24 2017-08-23 Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav

Country Status (16)

Country Link
US (1) US5550165A (no)
EP (1) EP0591275B1 (no)
JP (1) JP3130935B2 (no)
AT (1) ATE178207T1 (no)
AU (1) AU672361B2 (no)
CA (1) CA2072047C (no)
DE (2) DE122005000032I2 (no)
DK (1) DK0591275T3 (no)
ES (1) ES2129448T3 (no)
GR (1) GR3029841T3 (no)
IE (1) IE922024A1 (no)
LU (1) LU91180I2 (no)
NL (1) NL300198I2 (no)
NO (3) NO304923B1 (no)
PT (1) PT100619B (no)
WO (1) WO1993000080A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4305696A1 (de) * 1993-02-25 1994-09-01 Hoechst Ag Nachweisverfahren zur Identifizierung von Inhibitoren
EP1100520B1 (en) 1998-07-21 2004-09-22 Cytovia, Inc. Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
GB0504103D0 (en) * 2005-02-28 2005-04-06 Syngenta Ltd Novel method
EP2233136A1 (en) * 2006-08-18 2010-09-29 Syngenta Limited Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
PH12012501552A1 (en) * 2010-01-29 2017-04-26 Toray Industries Therapeutic or prophylactic agent for biliary diseases
UA110979C2 (uk) * 2011-06-23 2016-03-10 Сведіш Орфан Біовітрум Інтернешнл Аб Рідка фармацевтична композиція, яка включає нітизинон
WO2013181292A1 (en) * 2012-05-29 2013-12-05 Biotie Therapies, Inc. Nitisinone formulations
CN102976948B (zh) * 2012-11-28 2014-07-09 郑州大明药物科技有限公司 尼替西农的制备方法
GB201400117D0 (en) 2014-01-03 2014-02-19 Cycle Pharmaceuticals Ltd Pharmaceutical composition
ITUB20160650A1 (it) 2016-02-11 2017-08-11 Dipharma S A Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione
US9783485B1 (en) 2016-11-30 2017-10-10 Dipharma S.A. Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof
EP3888684A1 (en) * 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
CN112460914A (zh) * 2020-11-01 2021-03-09 江苏珠合新能源科技有限公司 一种干冰机尾气冷量回收调节工艺装置
WO2024047657A1 (en) * 2022-08-28 2024-03-07 Brawn Laboratories Ltd Process for the preparation of nitisinone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780127A (en) * 1982-03-25 1988-10-25 Stauffer Chemical Company Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides
IL77349A (en) * 1984-12-20 1990-07-12 Stauffer Chemical Co 2-(2'-nitrobenzoyl)-1,3-cyclohexanediones,their preparation and their use as herbicides
US4774360A (en) 1987-06-29 1988-09-27 Stauffer Chemical Company Converting enol ester precursor of a benzoyl-1,3-cycloalkyldione to a benzoyl-1,3-cycloalkyldione
US4859234A (en) 1987-09-14 1989-08-22 Ici Americas Inc. Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and phenoxyalkanoic acids, salts, amides and esters therof as antidotes

Also Published As

Publication number Publication date
NO2017045I1 (no) 2017-08-23
IE922024A1 (en) 1992-12-30
PT100619B (pt) 1999-07-30
NO304923B1 (no) 1999-03-08
CA2072047A1 (en) 1992-12-25
NO2005018I1 (no) 2005-09-26
GR3029841T3 (en) 1999-07-30
ATE178207T1 (de) 1999-04-15
PT100619A (pt) 1994-01-31
DE122005000032I2 (de) 2006-06-08
DE69228813T2 (de) 1999-08-05
NL300198I1 (nl) 2005-08-01
CA2072047C (en) 2003-06-10
EP0591275B1 (en) 1999-03-31
US5550165A (en) 1996-08-27
JPH06508628A (ja) 1994-09-29
DE69228813D1 (de) 1999-05-06
DK0591275T3 (da) 1999-10-11
NO934798D0 (no) 1993-12-23
HK1008662A1 (en) 1999-05-14
NL300198I2 (nl) 2005-09-01
LU91180I2 (fr) 2005-09-06
EP0591275A1 (en) 1994-04-13
AU672361B2 (en) 1996-10-03
NO934798L (no) 1993-12-23
JP3130935B2 (ja) 2001-01-31
AU1986092A (en) 1993-01-25
WO1993000080A1 (en) 1993-01-07
DE122005000032I1 (de) 2005-09-29
ES2129448T3 (es) 1999-06-16

Similar Documents

Publication Publication Date Title
NO2017045I1 (no) Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav
MY100194A (en) Liquid shampoo composition
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
DE69328682D1 (de) Lipide zur epidermalen Befeuchtung und zur Wiederherstellung der Barrierefunktion
ES2170335T3 (es) Estabilizacion de un retinoide inestable en emulsiones aceite en agua para composiciones para el cuidado de la piel.
EP1362846A4 (en) AMINOETHANOL DERIVATIVES
KR950031059A (ko) 골다공증 치료용 약제학적 조성물
BR0107157A (pt) Diagnose e tratamento de condições cardiovasculares
FR2354091A1 (fr) Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
FR2377203A1 (fr) Melange stable a la conservation donnant par dissolution dans l'eau une solution a haute activite antimicrobienne
BR9915090A (pt) Composto ou um sal do mesmo, peptìdeo ou um saldo mesmo, derivado de benzeno ou um sal domesmo, método para inibir ap-1, agente paraprevenir e tratar uma doença na qual participeuma sobre-expressão de ap-1 e uma doençaautoimune, e, inibidor de ap-1
Ebrahim et al. Effect of vitamin E and taurine treatment on lipid peroxidation and antioxidant defense in perchloroethylene-induced cytotoxicity in mice
CA2291650A1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
PA8429601A1 (es) Inhibicion de las metaloproteinasas de matriz por acidos 2-(w-aroilalquil)-4-biaril-4-oxobutiricos.
KR960703845A (ko) 페녹시페닐 사이클로펜테닐 하이드록시우레아(phenoxyphenyl cyclopentenyl hydroxyureas)
ATE230252T1 (de) Zusammensetzungen für durchsichtige kosmetischen stifte, die 2-methyl-1,3-propanediol enthalten
GB9126874D0 (en) Medicaments
JPS54101420A (en) Poultice and its preparation
PT966455E (pt) Acidos oxiranocarboxilicos para o tratamento da diabetes
BR0309019A (pt) Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas
FR3092492A1 (fr) Utilisation cosmétique d’un composé aminostéroïdien analogue de la squalamine pour diminuer ou prévenir une mauvaise odeur cutanée
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.